Wisdom Engraced
Keep up with the latest news and be part of our weekly giveaways and airtime sharing; follow our WhatsApp channel for more updates. Click to Follow us
The National Breast Cancer Foundation in Sydney, Australia, has awarded a significant grant of A$25 million ($16.3 million) to the Garvan Institute of Medical Research. The grant will support the AllClear research programme, led by Associate Professor Christine Chaffer, which aims to stop breast cancer recurrence.
The AllClear initiative brings together 60 researchers who will study cancer cells in the bone to understand how they hide, differ from primary tumour cells, and evade current treatments. By leveraging machine learning, molecular profiling, and biomarker discovery, the program seeks to improve cancer recurrence prediction, develop new therapies, and accelerate clinical trials
For further information, read more details here
Associate Professor Christine Chaffer emphasised the programme’s long-term goal, saying, “Our long-term goal is to reduce breast cancer deaths by half by tackling one of the most complex and urgent challenges in the field—preventing breast cancer from returning.” She added, “AllClear brings unprecedented collaboration to identify these ‘seeds’ of relapse early, allowing us to develop tools to predict who is most at risk of relapse and develop targeted therapies to eliminate these seeds of relapse.”
The AllClear program is a collaborative effort with St Vincent’s Hospital Sydney and UNSW Sydney, highlighting the importance of partnerships in advancing breast cancer research
Please don’t forget to “Allow the notification” so you will be the first to get our gist when we publish it.
Drop your comment in the section below, and don’t forget to share the post
